Australia markets closed

Xtacy Therapeutics Corp. (TT5.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
0.0230+0.0025 (+12.20%)
At close: 07:26PM CEST
Full screen
Previous close0.0205
Open0.0210
Bid0.0200 x N/A
Ask0.0425 x N/A
Day's range0.0195 - 0.0230
52-week range0.0050 - 0.1080
Volume0
Avg. volume761
Market capN/A
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings date05 Feb 2024 - 09 Feb 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    TESSCO Announces Closing of Merger Transaction

    HUNT VALLEY, Md., July 17, 2023--TESSCO TECHNOLOGIES INCORPORATED ("Tessco" or the "Company") today announced the closing of its previously announced merger with entities affiliated with Lee Equity Partners and Twin Point Capital, which also own Alliance Corporation ("Alliance"), a value-added distributor of equipment for the wireless industry, and GetWireless, LLC ("GetWireless"), a value-added distributor of cellular solutions that connect the Internet of Things (IoT). Tessco shareholders appr

  • Business Wire

    TESSCO Technologies Incorporated Receives Stockholder Approval to Merge and Announces Expected Merger Closing Date

    HUNT VALLEY, Md., July 13, 2023--(NASDAQ: TESS), TESSCO TECHNOLOGIES INCORPORATED ("Tessco" or the "Company") announced today that, at a Special Meeting of Stockholders held on July 13, 2023, Tessco stockholders approved the proposal to approve the merger transaction between Tessco and entities affiliated with Lee Equity Partners LLC and Twin Point Capital LLC, which also own Alliance Corporation ("Alliance"), a value-added distributor of equipment for the wireless industry, and GetWireless, LLC

  • Business Wire

    TESSCO Reports Fourth-Quarter Fiscal 2023 Financial Results

    HUNT VALLEY, Md., May 26, 2023--TESSCO TECHNOLOGIES INCORPORATED (NASDAQ: TESS) today reported financial results for its fiscal year 2023 fourth quarter, ended March 26, 2023.